Cargando…

4-[Bis(4-fluoro­phen­yl)meth­yl]piperazin-1-ium 2-hy­droxy­benzoate 2-hy­droxy­benzoic acid monosolvate

The title compound, C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (−)·C(7)H(6)O(3), is a co-crystal from 4-[bis­(4-fluoro­phen­yl)meth­yl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intra­molecular O—H⋯O hydrogen bond, the crystal packing shows hydrogen bonds betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dayananda, A. S., Yathirajan, H. S., Flörke, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344118/
https://www.ncbi.nlm.nih.gov/pubmed/22606121
http://dx.doi.org/10.1107/S1600536812012329
Descripción
Sumario:The title compound, C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (−)·C(7)H(6)O(3), is a co-crystal from 4-[bis­(4-fluoro­phen­yl)meth­yl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intra­molecular O—H⋯O hydrogen bond, the crystal packing shows hydrogen bonds between the piperazinium cation and salicylate anion (N—H⋯O), as well as between the salicylic acid mol­ecule and anion (O—H⋯O), giving rise to a three-dimensional network.